Gianotti-Crosti syndrome following childhood vaccinations

Michele Retrouvey1, Laine H Koch, Judith V Williams

  • 1Eastern Virginia Medical School, Norfolk, VA 23507, USA. retroum@evms.edu

Pediatric Dermatology
|December 7, 2011
PubMed

Insights

Gianotti-Crosti syndrome (GCS) is a rare skin condition that can occur after vaccinations. This case report explores the connection between GCS and childhood immunizations, including the DTaP and varicella vaccines.

Area of Science:

  • Pediatric Dermatology
  • Immunology
  • Vaccinology

Background:

  • Gianotti-Crosti syndrome (GCS) is an uncommon papular acrodermatitis primarily affecting children.
  • The etiology of GCS is often linked to viral infections, but vaccine-associated cases are increasingly reported.
  • Understanding potential adverse reactions to childhood immunizations is crucial for public health.

Observation:

  • A 19-month-old male presented with a characteristic skin eruption following recent vaccinations.
  • Clinical examination revealed typical features of GCS, including papules and vesicles predominantly on the extremities and face.
  • Histopathological analysis confirmed the diagnosis of Gianotti-Crosti syndrome.

Findings:

  • The patient had recently received the diphtheria, tetanus, and pertussis (DTaP) vaccine and the live varicella virus vaccine.
  • This case supports a potential association between GCS and specific childhood vaccines, namely DTaP and varicella.
  • Further investigation is warranted to elucidate the immunologic mechanisms linking these vaccines to GCS.

Implications:

  • This case highlights the importance of considering GCS in the differential diagnosis of vaccine-associated rashes in children.
  • Healthcare providers should be aware of the potential for GCS following DTaP and varicella vaccinations.
  • Continued surveillance and research are necessary to fully understand the incidence and pathogenesis of vaccine-associated GCS.

Related Concept Videos

Hypersensitivity Reactions: Immune-Complex Reactions01:19

Hypersensitivity Reactions: Immune-Complex Reactions

Type III hypersensitivity reactions occur when antigen–antibody complexes form and activate the complement system. Normally, these complexes help the clearance of antigens by phagocytes and red blood cells. However, when large numbers of immune complexes are present, they can deposit in tissues—particularly in the walls of blood vessels—leading to inflammation and tissue injury. These deposits trigger complement activation and neutrophil recruitment, resulting in serum sickness, a systemic...
Autoimmune Disorders01:29

Autoimmune Disorders

Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune system...
Vaccinations01:51

Vaccinations

Overview
Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
Hypersensitivity Reactions: Delayed Hypersensitivity Reactions01:29

Hypersensitivity Reactions: Delayed Hypersensitivity Reactions

Delayed-Type Hypersensitivity (DTH), or Type IV hypersensitivity, is a cell-mediated immune response. It occurs when T cells, rather than antibodies, mediate a reaction to specific antigens. It is characterized by a delayed onset (1-2 days) and involves the recruitment of macrophages to the inflammation site.The initiation of a DTH response begins with the sensitization of T cells. During this phase, which lasts at least 1-2 weeks, antigen-specific T cells are activated, clonally expanded, and...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...